BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 30057165)

  • 1. Hemodynamics and its predictors during Impella-protected PCI in high risk patients with reduced ejection fraction.
    Russo G; Burzotta F; D'Amario D; Ribichini F; Piccoli A; Paraggio L; Previ L; Pesarini G; Porto I; Leone AM; Niccoli G; Aurigemma C; Verdirosi D; Trani C; Crea F
    Int J Cardiol; 2019 Jan; 274():221-225. PubMed ID: 30057165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unprotected versus protected high-risk percutaneous coronary intervention with the Impella 2.5 in patients with multivessel disease and severely reduced left ventricular function.
    Becher T; Eder F; Baumann S; Loßnitzer D; Pollmann B; Behnes M; Borggrefe M; Akin I
    Medicine (Baltimore); 2018 Oct; 97(43):e12665. PubMed ID: 30412063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Impella protected-percutaneous coronary intervention on left ventricle function recovery of patients with extensive coronary disease and poor left ventricular function.
    Romagnoli E; Burzotta F; Cerracchio E; Russo G; Aurigemma C; Pedicino D; Locorotondo G; Graziani F; Leone AM; D'Amario D; Lombardo A; Malara S; Fulco L; Bianchini F; Sanna T; Trani C
    Int J Cardiol; 2023 Sep; 387():131098. PubMed ID: 37290663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Term Outcomes of Extent of Revascularization in Complex High Risk and Indicated Patients Undergoing Impella-Protected Percutaneous Coronary Intervention: Report from the Roma-Verona Registry.
    Burzotta F; Russo G; Ribichini F; Piccoli A; D'Amario D; Paraggio L; Previ L; Pesarini G; Porto I; Leone AM; Niccoli G; Aurigemma C; Verdirosi D; Crea F; Trani C
    J Interv Cardiol; 2019; 2019():5243913. PubMed ID: 31772533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous left ventricular assist device with TandemHeart for high-risk percutaneous coronary intervention: the Mayo Clinic experience.
    Alli OO; Singh IM; Holmes DR; Pulido JN; Park SJ; Rihal CS
    Catheter Cardiovasc Interv; 2012 Nov; 80(5):728-34. PubMed ID: 22378485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of five-year outcomes of coronary artery bypass grafting versus percutaneous coronary intervention in patients with left ventricular ejection fractions≤50% versus >50% (from the CREDO-Kyoto PCI/CABG Registry Cohort-2).
    Marui A; Kimura T; Nishiwaki N; Mitsudo K; Komiya T; Hanyu M; Shiomi H; Tanaka S; Sakata R;
    Am J Cardiol; 2014 Oct; 114(7):988-96. PubMed ID: 25124184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Six months follow-up of protected high-risk percutaneous coronary intervention with the microaxial Impella pump: results from the German Impella registry.
    Baumann S; Werner N; Al-Rashid F; Schäfer A; Bauer T; Sotoudeh R; Bojara W; Shamekhi J; Sinning JM; Becher T; Eder F; Akin I
    Coron Artery Dis; 2020 May; 31(3):237-242. PubMed ID: 31658135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-risk percutaneous coronary intervention with the TandemHeart and Impella devices: a single-center experience.
    Schwartz BG; Ludeman DJ; Mayeda GS; Kloner RA; Economides C; Burstein S
    J Invasive Cardiol; 2011 Oct; 23(10):417-24. PubMed ID: 21972160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous coronary intervention in patients with stable coronary artery disease and left ventricular systolic dysfunction: insights from the VA CART program.
    Brophy TJ; Warsavage TJ; Hebbe AL; Plomondon ME; Waldo SW; Rao SV; DeVore AD; Gutierrez JA; Swaminathan RV
    Am Heart J; 2021 May; 235():149-157. PubMed ID: 33567318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of mechanical left ventricular unloading by Impella on left ventricular dynamics in high-risk and primary percutaneous coronary intervention patients.
    Remmelink M; Sjauw KD; Henriques JP; de Winter RJ; Vis MM; Koch KT; Paulus WJ; de Mol BA; Tijssen JG; Piek JJ; Baan J
    Catheter Cardiovasc Interv; 2010 Feb; 75(2):187-94. PubMed ID: 19941329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-world use of the Impella 2.5 circulatory support system in complex high-risk percutaneous coronary intervention: the USpella Registry.
    Maini B; Naidu SS; Mulukutla S; Kleiman N; Schreiber T; Wohns D; Dixon S; Rihal C; Dave R; O'Neill W
    Catheter Cardiovasc Interv; 2012 Nov; 80(5):717-25. PubMed ID: 22105829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indication and short-term clinical outcomes of high-risk percutaneous coronary intervention with microaxial Impella® pump: results from the German Impella® registry.
    Baumann S; Werner N; Ibrahim K; Westenfeld R; Al-Rashid F; Sinning JM; Westermann D; Schäfer A; Karatolios K; Bauer T; Becher T; Akin I
    Clin Res Cardiol; 2018 Aug; 107(8):653-657. PubMed ID: 29520699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous retrograde left ventricular assist support for interventions in patients with aortic stenosis and left ventricular dysfunction.
    Martinez CA; Singh V; Londoño JC; Cohen MG; Alfonso CE; O'Neill WW; Heldman AW
    Catheter Cardiovasc Interv; 2012 Dec; 80(7):1201-9. PubMed ID: 22511541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aetiology and predictors of major bleeding events in patients with heart failure with reduced ejection fraction undergoing percutaneous coronary intervention.
    Iyer M; Shah R; Zheng W; Ziada KM; Khot U; Krishnaswamy A; Kapadia SR; Reed GW
    Open Heart; 2024 Apr; 11(1):. PubMed ID: 38663889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of left ventricular unloading by Impella recover LP2.5 on coronary hemodynamics.
    Remmelink M; Sjauw KD; Henriques JP; de Winter RJ; Koch KT; van der Schaaf RJ; Vis MM; Tijssen JG; Piek JJ; Baan J
    Catheter Cardiovasc Interv; 2007 Oct; 70(4):532-7. PubMed ID: 17896398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-risk percutaneous coronary intervention is associated with reverse left ventricular remodeling and improved outcomes in patients with coronary artery disease and reduced ejection fraction.
    Daubert MA; Massaro J; Liao L; Pershad A; Mulukutla S; Magnus Ohman E; Popma J; O'Neill WW; Douglas PS
    Am Heart J; 2015 Sep; 170(3):550-8. PubMed ID: 26385039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recovery of Left Ventricular Function After Percutaneous Coronary Intervention Compared to Coronary Artery Bypass Grafting in Patients with Multi-Vessel Coronary Disease and Left Ventricular Dysfunction.
    Yee NP; Siu AM; Davis J; Kao J
    Hawaii J Med Public Health; 2016 Sep; 75(9):273-7. PubMed ID: 27688953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronary revascularization for patients with severe left ventricular dysfunction.
    Nagendran J; Norris CM; Graham MM; Ross DB; Macarthur RG; Kieser TM; Maitland AM; Southern D; Meyer SR;
    Ann Thorac Surg; 2013 Dec; 96(6):2038-44. PubMed ID: 23968761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Mechanical Circulatory Support During Percutaneous Coronary Intervention in Patients Without Severely Depressed Left Ventricular Function.
    Alaswad K; Basir MB; Khandelwal A; Schreiber T; Lombardi W; O'Neill W
    Am J Cardiol; 2018 Mar; 121(6):703-708. PubMed ID: 29370923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Benefit of Successful Percutaneous Coronary Intervention for Chronic Total Occlusion in Patients With Versus Without Reduced (≤40%) Left Ventricular Ejection Fraction.
    Toma A; Stähli BE; Gick M; Gebhard C; Kaufmann BA; Mashayekhi K; Ferenc M; Buettner HJ; Neumann FJ
    Am J Cardiol; 2017 Nov; 120(10):1780-1786. PubMed ID: 28867125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.